National Institute Of Diabetes And Digestive And Kidney Diseases (niddk)
Clinical trials sponsored by National Institute Of Diabetes And Digestive And Kidney Diseases (niddk), explained in plain language.
-
Breakthrough search: finding the hidden signs of kidney shutdown
Diagnosis TerminatedThis study aims to discover new substances in blood and urine that signal early kidney damage. Researchers will compare samples from healthy people, those at risk, and patients with kidney failure to identify unique markers. The goal is to develop faster, more accurate tests so t…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
Race against time: can drug stop diabetes before it starts?
Prevention TerminatedThis study tested whether a low-dose immune therapy called ATG could delay or prevent the onset of type 1 diabetes in children and young adults at high risk. Participants were randomly assigned to receive either ATG or a placebo and were followed for several years. The trial aime…
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Prevention
Last updated Mar 19, 2026 14:55 UTC
-
Scientists gather clues to unlock cystic fibrosis mysteries
Knowledge-focused TerminatedThis study aimed to collect medical samples and information from people with cystic fibrosis (CF) during their regular doctor visits. The goal was to build a database for future research to better understand how the disease develops and varies between people. It did not test any …
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC